Glaukos is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Thomas William Burns, with a market cap of $6.9B.
Common questions about Glaukos
Glaukos is scheduled to report earnings for Q1 2026 on April 29, 2026. Analysts estimate revenue of $136.2M.
Glaukos has approximately 907 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.